Skip to main content
Premium Trial:

Request an Annual Quote

Camena Bioscience: Nicola Thompson

UK synthetic biology firm Camena Bioscience has appointed Nicola Thompson as chair of its board of directors. Previously, she was the founding CEO of Amphista Therapeutics, and before that, chair of the board of Nanna Therapeutics. She also held senior leadership roles at Roche. Thompson has a PhD in cell biology from University College London.